Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen Says Data Highlight Safety Profile For BG-12 MS Drug
FOX Business
Tuesday, April 24, 2012 - 10:27am
tags:
Biogen Idec, BG-12, multiple sclerosis, MS
Illumina Beats on Both Top and Bottom Lines
Motley Fool
Tuesday, April 24, 2012 - 10:11am
tags:
earnings, Illumina
J&J Sticking Together
Investopedia.com
Tuesday, April 24, 2012 - 10:07am
tags:
JNJ, Novartis, Pfizer, Abbott Laboratories, Zimmer, Stryker
Watson in Patent Infringement Lawsuit
Yahoo/Zacks
Tuesday, April 24, 2012 - 10:03am
tags:
patents, Watson Pharmaceuticals, Glumetz, Depomed
Ardea Biosciences: Shareholders Should Tender To AstraZeneca's Bid
Seeking Alpha
Tuesday, April 24, 2012 - 10:01am
tags:
Ardea, AstraZeneca, M&A
Human Genome Most Lucrative on Record Biotech Premiums
Bloomberg
Tuesday, April 24, 2012 - 10:01am
tags:
Human Genome Sciences, GSK, M&A
Nestle may sell part of Pfizer assets: report
Reuters
Tuesday, April 24, 2012 - 10:00am
tags:
Pfizer, M&A, Nestle, infant nutrition
Illumina And Human Genome: Reasons For Rejections Of Takeovers
Seeking Alpha
Monday, April 23, 2012 - 12:15pm
tags:
M&A, Illumina, Roche, Human Genome Sciences, GSK
Forbes Earnings Preview: Gilead Sciences
Forbes
Monday, April 23, 2012 - 12:13pm
tags:
earnings, Gilead
InterMune Inc. First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, April 23, 2012 - 12:13pm
tags:
earnings, InterMune
Alexion Q1 Profit Expected To Continue Growth Streak
Investors.com
Monday, April 23, 2012 - 12:12pm
tags:
earnings, Alexion
Novartis blueprints $550M Swiss drug plant after layoffs backlash
Fierce Pharma
Monday, April 23, 2012 - 11:59am
tags:
Novartis, Switzerland, drug manufacturing
Is AstraZeneca Pharma’s Best Kept Secret?
Motley Fool
Monday, April 23, 2012 - 11:57am
tags:
AstraZeneca
Galena Biopharma: How Long Can Big Pharma Wait?
Seeking Alpha
Monday, April 23, 2012 - 11:10am
tags:
Galena Biopharma, Roche, NeuVax, breast cancer
Biota Falls Most in Eight Months on Merger with Nabi
Bloomberg
Monday, April 23, 2012 - 11:08am
tags:
Nabi, Biota, M&A
Astra fuels biotech M&A with $1.3 billion Ardea buy
Reuters
Monday, April 23, 2012 - 11:07am
tags:
Ardea, AstraZeneca, M&A
Ziopharm: A Short Squeeze In The Making?
Seeking Alpha
Monday, April 23, 2012 - 11:06am
tags:
Ziopharm, oncology
A Hot Time for Health Care Deals
NY Times, NY
Monday, April 23, 2012 - 10:41am
tags:
M&A, Pfizer, Nestle, Ardea, AstraZeneca
Earnings Preview: Bristol-Myers
Yahoo/Zacks
Monday, April 23, 2012 - 10:33am
tags:
Bristol-Myers Squibb, earnings
Amylin reportedly hires advisors to find a buyer
Marketwatch
Monday, April 23, 2012 - 9:42am
tags:
Amylin, M&A, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.